NCT03589729
- Conditions
- Acute Myeloid Leukemia, Blast Crisis, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +25 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Philadelphia Chromosome Positive
Explore clinical trials studying Philadelphia Chromosome Positive. Study availability and eligibility vary by location and protocol.
13 public trials
3 recruiting studies
Philadelphia Chromosome Positive trial results
NCT03263572
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein Expression, +29 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT05007873
- Conditions
- BCR-ABL1 Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia, Bone Marrow Diseases, +15 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT07178912
- Conditions
- Blinatumomab, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT02997761
- Conditions
- Adult B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +16 more
- Locations
-
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT01190930
- Conditions
- Abnormalities, Multiple, Acute Lymphoblastic Leukemia, Adult B Lymphoblastic Lymphoma, +28 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- USA Health Strada Patient Care Center Mobile, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
NCT02458014
- Conditions
- Adult Acute Lymphoblastic Leukemia in Complete Remission, B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +22 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00390793
- Conditions
- Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein Expression, Blast Crisis, +26 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Study to Evaluate Nilotinib in Chronic Myelogenous Leukemia (CML) Patients With SubOptimal Response
NCT01043874
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia in Chronic Phase, +12 more
- Locations
-
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Aomori, Japan
Active, Not Recruiting
Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell Malignancies
NCT03241940
- Conditions
- B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CD19 Positive, +29 more
- Locations
-
- Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States